Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 5173
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
49181
Good reminder to folks on the value of B-OM. A
Trading Pro Broker
09/24/2018 7:33:06 AM
49180
Very good discussion you started, like to see
bejamin
09/24/2018 7:31:39 AM
49179
https://mailchi.mp/ipharminc/innovation-pharmaceu
(1)
Commando911
09/24/2018 7:23:44 AM
49178
I know I'm not a fan of those who attempt to
(1)
BooDog
09/24/2018 7:23:39 AM
49177
and a PR on OM
smokenhot
09/24/2018 7:16:38 AM
49176
New B-OM comparison Blog
(2)
smokenhot
09/24/2018 7:02:28 AM
49175
IMO A big Pharma is doing due diligence and found
zdubble17
09/23/2018 11:08:54 PM
49174
I agree...but Im not concerned. If money were
Commando911
09/23/2018 10:25:10 PM
49173
No, it's not medical semantics. You're making a
(5)
Drano
09/23/2018 8:35:45 PM
49172
I think I love you!!! Kelt
Kelt
09/23/2018 8:33:16 PM
49171
Seemingly contrary. Over differences are over
(1)
RusticBum
09/23/2018 8:19:10 PM
49170
Nothing strange at all about not paying someone
(2)
Drano
09/23/2018 7:52:35 PM
49169
No, the board is not "alarmingly paranoid."
(5)
Drano
09/23/2018 7:50:29 PM
49168
The timing just seems weird to me. IPIX is close
smokenhot
09/23/2018 7:37:17 PM
49167
What makes you think that lesions show up fully
(2)
RusticBum
09/23/2018 5:27:56 PM
49166
My bet is you get to stock the Scotch, maybe
incubus
09/23/2018 5:14:05 PM
49165
Please don't let facts get in the way of your
(4)
Drano
09/23/2018 4:37:48 PM
49164
As you said Brilacidin does not have systemic
(2)
RusticBum
09/23/2018 4:17:29 PM
49163
Well here we are folks at the last trading week
(12)
Kelt
09/23/2018 1:42:25 PM
49162
Ahhh Yes. A little word twisting here,a little
(2)
Kelt
09/23/2018 1:40:12 PM
49161
Menon is in his mid-70's and was already on half
Drano
09/23/2018 1:36:55 PM
49160
Is it possible that Menon's termination has
smokenhot
09/23/2018 1:18:21 PM
49159
We have only people's word for it that they are
(2)
Drano
09/23/2018 12:58:15 PM
49158
That is incorrect. Bril-OM PREVENTS lesions from
(6)
Drano
09/23/2018 12:40:39 PM
49157
If both Galera's GC4419 and Brilacidin get
(1)
RusticBum
09/23/2018 11:57:00 AM
49156
Accusing long term investors of being short multi
(2)
bejamin
09/23/2018 11:42:25 AM
49155
It's always good to have more than one treatment
(3)
Drano
09/22/2018 3:41:30 PM
49154
Could be a second line treatment after B-OM was
Trading Pro Broker
09/22/2018 3:36:35 PM
49153
NO way will an insurance company pay for that
(2)
smokenhot
09/22/2018 3:24:06 PM
49152
He's accusing long-time posters of being
(5)
Drano
09/22/2018 2:27:16 PM
49150
Take a look at Galas OM drug. Its
(1)
Trading Pro Broker
09/22/2018 1:38:41 PM
49149
Id like to see Leo take half his compensation
(2)
Commando911
09/22/2018 1:19:15 PM
49148
I have never heard of a long multi-identity in
(2)
petemantx
09/22/2018 1:10:28 PM
49147
Your right. That would be
Trading Pro Broker
09/22/2018 11:11:42 AM
49146
A reminder on how to use the Ignore feature:
Drano
09/22/2018 11:02:08 AM
49145
It's typical of many companies to have a large
(4)
Drano
09/22/2018 11:00:23 AM
49144
Multi identities on both sides create so much
(2)
bejamin
09/22/2018 10:59:06 AM
49143
I dont think it is a surprise. If it surprises
Trading Pro Broker
09/22/2018 10:48:51 AM
49142
Glad you're not running the company!
(1)
bejamin
09/22/2018 10:43:09 AM
49141
really, it is better not to respond to trolling
(1)
Drano
09/22/2018 10:00:01 AM
49140
So you think IPIX will begin testing on autism,
(1)
smokenhot
09/22/2018 9:01:20 AM
49139
Well seeing as you came from Yahoo I can
bejamin
09/22/2018 5:10:05 AM
49138
I don't know why this comes as any surprise. Dr.
(12)
Drano
09/21/2018 9:59:42 PM
49137
Yup 1 month here and 5 years on Yahoo. Maybe you
(4)
smokenhot
09/21/2018 9:19:33 PM
49136
No they have not. IPIX has other pre clinical
bejamin
09/21/2018 8:48:07 PM
49135
They have ALL gone thru Pre Clinical. What don't
smokenhot
09/21/2018 8:25:49 PM
49134
To bring new drugs online. IPIX has other drugs
bejamin
09/21/2018 7:37:42 PM
49133
Why would they restart R&D? They are a clinical
(2)
smokenhot
09/21/2018 6:31:27 PM
49132
Arent 18M of those options? Cant exercise
Trading Pro Broker
09/21/2018 6:25:43 PM
49131
As of 6/19/18 Menon has over 33M reasons to see
(1)
Mo
09/21/2018 6:06:58 PM
Newer
Older
Recent Articles
T-Mobile US's Impressive Growth: A 10-Year Investment Story
BlackSky Technology Experiences Significant Stock Price Decline
Capricor Therapeutics Hit With Securities Fraud Lawsuit
Capricor Therapeutics Faces Class Action Amid Stock Decline
Johnson & Johnson: Analyzing Recent Market Trends and Patterns
Citius Oncology Completes $9 Million Offering for Growth
BrainStorm Cell Therapeutics Transitioning to OTCQB After Nasdaq Delisting
United Bancshares Reports Strong Q2 2025 Financial Performance
CenterPoint Energy Alerts Customers on Invest 93L Storm Preparedness
Con Edison Announces Quarterly Dividend for Stockholders
Weis Markets Declares Positive Quarterly Dividend for Shareholders
Society of Industrial and Office Realtors Announces New Leaders
XPLR Infrastructure Faces Class Action: Understand Your Rights
Dow Jones Analysis: Technical Insights and Bullish Trends Ahead
PCI Promatec Strengthens Position by Joining Texas Nuclear Alliance
UroGen Pharma Investors Alert: Class Action Dates and Details
Omada Health Set to Report Q2 2025 Results and Insights
iRhythm Technologies to Reveal Q2 2025 Financial Outcomes Soon
Dynamite Blockchain's Strategic Move with New Private Placement
Exciting Updates from illumin Holdings Regarding Q2 2025 Results
Globus Medical Plans Major Earnings Announcement for Investors
Hapbee Technologies Achieves $1M Milestone with Insider Purchase
P10 Sets Date for Q2 2025 Earnings Announcement
Omada Health's Upcoming Q2 2025 Results and Conference Details
Turning $1000 into $3500: A Look at Krystal Biotech
Dime Community Bancshares Earns Prestigious Lending Award
Leslie's Inc. Set to Report Fiscal 2025 Financial Insights
Mega Fortune Company Completes Successful $15 Million IPO Launch
Netflix Grows Revenue in Q2: What's Next for NFLX?
Basel Medical Group Delays BTC Acquisition Amid Regulations
Canaan Inc. Collaborates to Enhance Bitcoin Mining Capabilities
Globus Medical Announces Earnings Call to Discuss Q2 Results
illumin Holdings Inc. Set to Release Q2 2025 Financial Results
Cannabis Market Update: Top Movers You Should Know About
iRhythm Technologies Set to Announce Q2 2025 Financials Soon
Latest Trends in National Housing Market Analysis
P10, Inc. Set to Release Q2 2025 Earnings on August 7
Leslie’s Announces Upcoming Fiscal 2025 Financial Results Release
Record-Breaking Crypto Real Estate Opportunity in California
CMB.TECH and Golden Ocean Merger Progress Report
Exploring A Bearish Options Strategy With Labcorp Holdings
Evaluating OR Royalties Stock's Performance Over Five Years
Draganfly's Recent Military Contract Sparks Stock Surge
Shiner Law Group Expands with Two New Talented Attorneys
Quaker Houghton Prepares for Strong Q2 2025 Earnings Release
BancFirst Corporation's Impressive Earnings Boost
BrainStorm Cell Therapeutics Shifts from Nasdaq to OTCQB Trading
John Hancock Funds Announce Positive Earnings Insights
Cohen & Steers Reports Strong Financial Results for Q2 2025
Energizer Holdings, Inc. Prepares for Third Quarter Earnings Call